Skip to main content

Find Clinical Trials

Home
Conditions
Adenoma

Clinical trial condition

Adenoma

Explore clinical trials studying Adenoma. Study availability and eligibility vary by location and protocol.

597 public trials 137 recruiting studies

Refine in advanced search Browse all conditions

Adenoma trial results

Recruiting

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

NCT07443020

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +17 more
Locations: AHN West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

NCT06444815

Conditions: Adenocarcinoma, Adenoma, Bronchial Neoplasms, +56 more
Locations: USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

UC Irvine Health Orange, California, United States

University of Miami Miami, Florida, United States

Community Health Network Indianapolis, Indiana, United States

View Trial Details

Recruiting

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

NCT07510815

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

NCT04665206

Conditions: Adenoma, Mesothelioma, NSCLC, +5 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University of Chicago Medical Center Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

NCT05655078

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: East Sussex Healthcare NHS Trust - Eastbourne Hospital Eastbourne, East Sussex, United Kingdom

East Sussex Healthcare NHS Trust - Conquest Hospital Saint Leonards-on-Sea, East Sussex, United Kingdom

Royal Berkshire Hospital Reading, England, United Kingdom

Southend University Hospital Southend, Essex, United Kingdom

View all 25 locations

View Trial Details

Recruiting

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

NCT05477576

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: Research Facility Phoenix, Arizona, United States

Research Facility Duarte, California, United States

Research Facility Irvine, California, United States

Research Facility Los Angeles, California, United States

View all 54 locations

View Trial Details

Recruiting

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

NCT05847855

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +11 more
Locations: Fudan University shanghai cancer center Shanghai, Shanghai Municipality, China

West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

NCT06840834

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Besançon - CHU Besançon, France

Brest - CHU Brest, France

Caen - CHU Caen, France

Clermont-Ferrand - Centre Jean Perrin Clermont-Ferrand, France

View all 20 locations

View Trial Details

Recruiting

Safety and Potency of a High Cabergoline Dosage in Microprolactinomas

NCT07463235

Conditions: Adenoma, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: UFMG Belo Horizonte, Brazil

Unesp Botucatu, Brazil

UNB Brasília, Brazil

Unicamp Campinas, Brazil

View all 16 locations

View Trial Details